Bristol-Myers Squibb Co and Pfizer Inc
Eliquis (apixaban) is a factor Xa inhibitor anticoagulant indicated to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. The recommended dose for most patients is 5 mg orally twice daily. The recommended dose is 2.5 mg orally once daily for patients with at least 2 of the following characteristics: 80 years or older, body weight 60 kg or greater, and serum creatinine 1.5 mg/dL or greater. The product carries a boxed warning against an increased risk of stroke in patients who discontinue Eliquis without adequate continuous anticoagulation.
Tablets: 2.5 and 5 mg
For More Information: www.eliquis.com
Amarin Pharma Inc
The FDA approved Vascepa (icosapent ethyl) capsules as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. Vascepa is an ethyl ester of eicosapentaenoic acid. Before initiating treatment, lipid levels should be assessed and other causes for hypertriglyceridemia should be managed. A lipid-lowering diet and exercise regimen should be initiated prior to and throughout treatment with Vascepa. Vascepa should be dosed as 2 g twice daily with food, for a total daily dose of 4 g. The capsules should be swallowed whole and never opened, crushed, dissolved, or chewed.
Capsules: 1 g
For More Information: www.vascepa.com
The FDA approved Botox (onabotulinumtoxinA) for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency in adults who have had an inadequate response to or are intolerant of anticholinergic medication. For the new indication, the recommended total dose is 100 units as 0.5-mL (5 unit) injections across 20 sites into the detrusor. Botox has a boxed warning against the risk of distant spread of toxin effect.
Injection: Single-use, sterile 100- or 200-unit vacuum-dried powder for reconstitution only with sterile, nonpreserved 0.9% sodium chloride injection USP prior to injection
For More Information
Noven Pharmaceuticals Inc
Minivelle (estradiol transdermal system) is now available by prescription in US pharmacies. Minivelle is an estrogen indicated for the treatment of moderate to severe vasomotor symptoms due to menopause. Therapy should be initiated at a dose of 0.0375 mg/day applied to the skin twice weekly. The smallest estrogen patch currently available, Minivelle should be placed on a clean, dry place on the lower abdomen or buttocks. It carries a boxed warning against increased risk of endometrial cancer, cardiovascular disorders, breast cancer, and probably dementia.
Transdermal system: 0.0375, 0.05, 0.075, 0.1 mg/day
For More Information: www.minivelle.com
Alcon announced the launch of Ilevro (nepafenac ophthalmic suspension), 0.3% , a nonsteroidal, anti-inflammatory prodrug indicated for the treatment of pain and inflammation associated with cataract surgery. One drop of Ilevro should be applied to the affected eye once daily beginning 1 day prior to cataract surgery, on the day of surgery, and through the first 2 weeks after the operation. An additional drop should be administered 30 to 120 minutes before surgery.
Sterile ophthalmic suspension 0.3%: 1.7 mL in a 4-mL bottle
For More Information: www.alcon.com
OB Complete Petite
Vertical Pharmaceuticals announced the launch of OB Complete Petite, the newest addition to the OB Complete line of prescription prenatal vitamins, which includes OB Complete One and OB Complete Premier. One of the smallest, easiest-to-swallow softgel capsules currently on the market, OB Complete Petite is complete with vitamins and minerals and has a vanilla scent. The recommended dose is 1 softgel once daily. Information about an instant savings program is available on the Vertical Pharmaceuticals website.
For More Information: www.verticalpharma.com
: Teva Respiratory, LLC, a subsidiary of Teva Pharmaceutical Industries Ltd
Teva Respiratory announced the availability of ProAir HFA (albuterol sulfate) Inhalation Aerosol with dose counter. ProAir HFA is indicated for patients 4 years and older for the treatment or prevention of bronchospasm with reversible obstructive airway disease and for the prevention of exercise-induced bronchospasm. The dose counter is designed to help patients and their caregivers track the number of doses remaining in the canister.
Inhalation aerosol: 108 mcg albuterol sulfate per actuation
For More Information: www.proairhfa.com